tiprankstipranks

Rachel King Insider Profile

11 Followers
Rachel King, Director at GlycoMimetics, holds 18.92K shares in Novavax (Ticker: NVAX), holds 659.10K shares in GlycoMimetics (Ticker: GLYC), holds ― shares in Fulcrum Therapeutics (Ticker: FULC).
tipranks
Rachel King

Rachel King
GlycoMimetics (GLYC)
Director

Ranked #76,613 out of 99,635 Corporate Insiders

Profitable Transactions

25%
1 out of 4 Profitable Transactions

Average Return

-21.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$365K
51.75%
48.25%
0.00%
A breakdown of Rachel King's holdings

Insider Roles

GlycoMimetics
(GLYC)
Director
Novavax
(NVAX)
Director
Fulcrum Therapeutics
(FULC)
Director
Roles that Rachel King holds in companies

Most Profitable Insider Trade

Stock:
Novavax
(NVAX)
Rating:Informative Buy
Date:Mar 28, 2019 - Mar 28, 2020
Return:+20.80%
The most profitable trade made by Rachel King

Rachel King's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
GlycoMimetics
Apr 02, 2024
Director
Uninformative Buy
10.00K
$189.16K
Novavax
Jun 14, 2024
Director
Uninformative Buy
105.79K
$176.33K
Fulcrum Therapeutics
Director
List of latest transactions for each holding click on a transaction to see Rachel King's performance on stock

Rachel King insider profile FAQ

What is the percentage of profitable transactions made by Rachel King?
The percentage of profitable transactions made by Rachel King is 25%.
    What is the average return per transaction made by Rachel King?
    The average return per transaction made by Rachel King is -21.30%.
      What stocks does Rachel King hold?
      Rachel King holds: GLYC, NVAX, FULC stocks.
        What was Rachel King’s latest transaction?
        Rachel King latest transaction was an Uninformative Buy of $105.79K.
          What was Rachel King's most profitable transaction?
          Rachel King’s most profitable transaction was an Informative Buy of NVAX stock on March 28, 2019. The return on the trade was 20.80%.
            What is Rachel King's role in GlycoMimetics?
            Rachel King's role in GlycoMimetics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.